Table 1

Clinicopathological features and endostatin gene expression

Clinicopathological featuresEndostatin gene expressionP
Median (range)
Age at the time of diagnosis0.984
 ≤50 yrs (n = 26)0.13 (0.02–0.83)
 >50 yrs (n = 38)0.14 (0.03–1.11)
FIGO stage0.009
 I–II (n = 28)0.10 (0.02–0.60)
 III–IV (n = 36)0.17 (0.04–1.11)
Residual disease0.005
 ≤2 cm (n = 42)0.10 (0.02–1.04)
 >2 cm (n = 22)0.22 (0.04–1.11)
Histological subtype0.879
 Serous (n = 27)0.16 (0.03–1.04)
 Mucinous (n = 18)0.10 (0.02–1.11)
 Endometrioid (n = 13)0.14 (0.04–0.83)
 Clear cell (n = 4)0.06 (0.03–0.60)
Histological grade0.335
 LMP (n = 7)0.10 (0.03–0.22)
 Well differentiated (n = 13)0.16 (0.05–0.60)
 Moderately differentiated (n = 24)0.14 (0.04–0.83)
 Poorly differentiated (n = 20)0.16 (0.02–1.11)